sign free newsletters sign free newsletters need better molecular biomarkers create targeted drugs alzheimer disease sixth leading cause death u.s. unlike cancer heart disease lack tools effectively diagnose treat sharp contrast illnesses despite efforts huge expense hundreds clinical trials new treatments approved past 16 years emphasis drugs targeting beta amyloid proteins clump plaques brains afflicted people unfortunately approaches not yielded results hoped time target novel pathways tackle incredibly complex disease challenge absence affordable noninvasive tests based biomarkers doctors easily use offices alternatives expensive invasive spinal taps neuroimaging tests performed hospital freestanding radiology office new biomarkers needed specific molecular targets subtype